J&J Wins Expansion for Top-Selling Cancer Drug in First for Smoldering Multiple Myeloma

By /

Darzalex Faspro’s approval for smoldering multiple myeloma could allow for earlier intervention and reduce the risk of progression to active disease.

Scroll to Top